Marek Poszepczynski – Startup Investor Profile

Marek Poszepczynski, an Investment Manager at SV Health Investors, is known for his specialization in the healthcare sector with a focus on biotechnology, medical devices, and digital health. SV Health Investors has a proven strategy for selecting healthcare investments across various stages, geographic regions, and sectors. Marek has a track record that includes managing the International Biotechnology Trust and working on the Dementia Discovery Funds. The average investment check size from SV Health Investors ranges from 10 to 50 million dollars per startup. Marek’s professional career started as an analyst in 2014 before becoming a named manager of the trust in 2017. His collaboration style is reflected in his active management of diversified portfolios and his optimism about the biotech sector’s recovery post-Covid, emphasizing the importance of humility and appreciating industry trends.

Location: Stockholm, Sweden

Country: Poland

Investment Regions: EU, NA

Investment Stages: pre-seed, seed

Website: https://www.svhealthinvestors.com/

AI Reasoning: I found a February 2025 announcement that SV Health (associated with Marek Poszepczynski) initiated an investment in AdvanCell Therapeutics. The investment date (February 2025) is less than 6 months before the reference date, so classify as very-active. Startup invested: AdvanCell Therapeutics.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.